Validation of Falls Decision Rule to Exclude Intracranial Bleeding in Geriatric Fall Patients
External Validation of the Falls Decision Rule to Exclude Intracranial Bleeding Without Head CT in Geriatric Patients Presenting to the Emergency Department With A Fall
1 other identifier
observational
800
1 country
1
Brief Summary
Although falls are the most important cause of intracranial hemorrhage in the population over 65, studies have shown that bleeding occurs in only 5% of geriatric patients who fall. Guidelines have been developed to assist the clinician in identifying patients at risk of intracranial hemorrhage due to the relatively low incidence but significant morbidity and mortality. The 'Falls Decision Rule' was developed by de Wit et al. in 2023 to assess the need for CT in this patient group. In this study, external validation of this newly developed score was planned to evaluate its safety, applicability, and authenticity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2024
CompletedFirst Submitted
Initial submission to the registry
July 24, 2024
CompletedFirst Posted
Study publicly available on registry
July 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2024
CompletedResults Posted
Study results publicly available
July 30, 2025
CompletedJanuary 22, 2026
January 1, 2026
9 months
July 24, 2024
February 16, 2025
January 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With the Clinically Important Intracranial Bleeding
The primary outcome is 'clinically significant intracranial hemorrhage' identified within 42 days following the initial presentation in the emergency department. 'Clinically significant intracranial hemorrhage' is defined as hemorrhage within the cranial vault, encompassing subdural, intracerebral, intraventricular, subarachnoid, epidural hemorrhage, and cerebral contusion, necessitating medical or surgical intervention. Medical intervention is defined as any of the following actions: temporary or permanent cessation of anticoagulant or antiplatelet medications; administration of an antifibrinolytic agent; reversal of anticoagulation; or hospitalization for neurological monitoring. These criteria align with those established in the original study.
From baseline to 42 days (Patients will be followed up for 42 days after the fall and evaluated for delayed intracranial haemorrhage).
Secondary Outcomes (2)
Number of Participant With Neurosurgical Intervention
42 day
Number of Patients With Mortality
42 day
Study Arms (1)
Patients aged 65 years and over
Patients aged 65 years and over who came to the emergency department with a fall on level ground ((either inside or outside), off a chair, toilet seat or out of bed) within the last 48 hours
Interventions
The Falls Decision Rule is a rule used to assess the risk of intracranial haemorrhage in geriatric patients and to prevent brain tomography (CT) in low-risk patients. This rule recommends that brain CT is not necessary in patients who do not have significant head trauma, memory loss, newly developing neurological examination disorder, or frailty score lower than 5 after a fall.
Eligibility Criteria
The study population consists of geriatric patients aged 65 years and older who present to the emergency department within 48 hours of experiencing a fall on level ground ((either inside or outside), off a chair, toilet seat, or out of bed). These patients will be included if they provide informed consent or if their legal guardians provide consent if the patients are unable to do so. The study aims to externally validate the Falls Decision Rule to exclude intracranial bleeding in this specific population. All patients meeting the inclusion criteria and none of the exclusion criteria will be enrolled in the study, and they will be observed for clinically significant intracranial bleeding for up to 42 days post-fall.
You may qualify if:
- Patients aged 65 years and older.
- Patients who presented to the emergency department within 48 hours of a fall.
- Patients who provided informed consent to participate in the study or whose legal guardians provided consent if the patients are unable to do so.
You may not qualify if:
- Patients who have already been included in the study previously.
- Patients who refuse medical treatment or withdraw consent during the study period.
- Patients with incomplete data necessary for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University Pendik Training and Research Hospital
Istanbul, Pendik, Turkey (Türkiye)
Related Publications (2)
Gray I, de Wit K. Fast-tracking falls - expediting emergency care with evidence. CJEM. 2025 Aug;27(8):580-581. doi: 10.1007/s43678-025-00970-x. No abstract available.
PMID: 40856903RESULTKudu E, Altun M, Danis F, Karacabey S, Sanri E, Denizbasi A. Validating the falls decision rule: optimizing head CT use in older adults with ground-level falls. CJEM. 2025 Aug;27(8):629-637. doi: 10.1007/s43678-025-00937-y. Epub 2025 May 13.
PMID: 40360963RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This study has limitations, primarily its single-center design, which may limit generalizability. However, as an external validation study, the findings suggest applicability to broader populations. Variability in physician judgment on CT use is another limitation, despite standardized training. Not all patients underwent CT at the initial visit, posing a risk of missed CIIB. However, a 42-day follow-up ensured comprehensive assessment, with no patients lost to follow-up.
Results Point of Contact
- Title
- Dr. Emre Kudu
- Organization
- Marmara University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
July 24, 2024
First Posted
July 29, 2024
Study Start
January 20, 2024
Primary Completion
October 1, 2024
Study Completion
November 12, 2024
Last Updated
January 22, 2026
Results First Posted
July 30, 2025
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share